AI assistant
Sending…
Q32 Bio Inc. — Director's Dealing 2020
Jul 21, 2020
34891_dirs_2020-07-21_f566180b-ec05-429f-a907-7650509cb874.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2020-07-21
Reporting Person: Poulton Jeffrey V. (Director)
More from Q32 Bio Inc.
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 24
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Feb 27